Literature DB >> 21827407

The ABC of the blood-brain barrier - regulation of drug efflux pumps.

Anne Mahringer1, Melanie Ott, Isolde Reimold, Valeska Reichel, Gert Fricker.   

Abstract

According to the World Health Organization Central nervous system disorders are the major medical challenge of the 21st Century, yet treatments for many CNS disorders are either inadequate or absent. One reason is the existence of the blood-brain barrier, which strictly limits the access of substances to the brain. A key element of the barrier function is the expression of ABC export proteins in the luminal membrane of brain microvessel endothelial cells. Understanding the signaling cascades and the response to endogenous and exogenous stimuli, which lead to altered expression or function of the transporters as well as subsequent modulation of the transporters, may offer novel strategies to overcome the barrier and to improve drug delivery to the brain. This review gives a short overview about structure of the key elements of the blood-brain barrier with emphasis on ABC transporters. An insight into regulation of function and expression of these transport proteins is given and the involvement of these transporters in CNS diseases is discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21827407     DOI: 10.2174/138161211797440221

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  18 in total

Review 1.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

Review 2.  Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?

Authors:  Wazir Abdullahi; Thomas P Davis; Patrick T Ronaldson
Journal:  AAPS J       Date:  2017-04-26       Impact factor: 4.009

3.  Alcohol and Cocaine Exposure Modulates ABCB1 and ABCG2 Transporters in Male Alcohol-Preferring Rats.

Authors:  Alaa M Hammad; Fawaz Alasmari; Youssef Sari; F Scott Hall; Amit K Tiwari
Journal:  Mol Neurobiol       Date:  2018-07-06       Impact factor: 5.590

4.  Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier - from Targeting to Safe Administration.

Authors:  Maria João Gomes; Carlos Fernandes; Susana Martins; Fernanda Borges; Bruno Sarmento
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-21       Impact factor: 4.147

5.  Overcoming blood-brain barrier transport: Advances in nanoparticle-based drug delivery strategies.

Authors:  Shichao Ding; Aminul Islam Khan; Xiaoli Cai; Yang Song; Zhaoyuan Lyu; Dan Du; Prashanta Dutta; Yuehe Lin
Journal:  Mater Today (Kidlington)       Date:  2020-03-04       Impact factor: 31.041

6.  Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures.

Authors:  Amber Dahlin; Ethan Geier; Sophie L Stocker; Cheryl D Cropp; Elena Grigorenko; Michele Bloomer; Julie Siegenthaler; Lu Xu; Anthony S Basile; Diane D-S Tang-Liu; Kathleen M Giacomini
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

7.  Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease.

Authors:  Shilpa Narayan; Janet S Sinsheimer; Kimberly C Paul; Zeyan Liew; Myles Cockburn; Jeff M Bronstein; Beate Ritz
Journal:  Environ Res       Date:  2015-10-19       Impact factor: 6.498

Review 8.  Physiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug delivery.

Authors:  Gwen McCaffrey; Thomas P Davis
Journal:  J Investig Med       Date:  2012-12       Impact factor: 2.895

Review 9.  Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites.

Authors:  Mahmoud Zaki El-Readi; Ahmed M Al-Abd; Mohammad A Althubiti; Riyad A Almaimani; Hiba Saeed Al-Amoodi; Mohamed Lotfy Ashour; Michael Wink; Safaa Yehia Eid
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

10.  Multiple sclerosis and the blood-central nervous system barrier.

Authors:  Alan M Palmer
Journal:  Cardiovasc Psychiatry Neurol       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.